Solid Biosciences to Present at 2025 Neuromuscular Study Group Annual Scientific Meeting

Benzinga
2025.09.25 12:36
portai
I'm PortAI, I can summarize articles.

CHARLESTOWN, Mass., Sept. 25, 2025 ( GLOBE NEWSWIRE ) -- Solid Biosciences Inc. ( NASDAQ: SLDB ) , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will present data from the Phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, a ...

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.